Environmental Health Science. Brian S. Schwartz, MD, MS



Similar documents
THE VIRTUAL DATA WAREHOUSE (VDW) AND HOW TO USE IT

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

The FDA s Mini- Sen*nel Program and the Learning Health System

Beacon User Stories Version 1.0

Secondary Uses of Data for Comparative Effectiveness Research

STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS

Meaningful Use Stage 2 Certification: A Guide for EHR Product Managers

MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Natalia Olchanski, MS, Paige Lin, PhD, Aaron Winn, MPP. Center for Evaluation of Value and Risk in Health, Tufts Medical Center.

Summary of the Proposed Rule for the Medicare and Medicaid Electronic Health Records (EHR) Incentive Program (Eligible Professionals only)

Meaningful Use Reporting Quick Reference

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2014

Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012

DEMONSTRATING MEANINGFUL USE STAGE 1 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EHR TECHNOLOGY IN 2015

Lunch and Learn IFAF 09/24/11. Michael L. Brody, DPM

Guide To Meaningful Use

VIII. Dentist Crosswalk

Attesting for Meaningful Use Stage 2 in 2014 Customer Help Guide

Stage 1 Meaningful Use - Attestation Worksheet: Core Measures

Stage 1 vs. Stage 2 Comparison Table for Eligible Professionals Last Updated: August, 2012

STAGES 1 AND 2 REQUIREMENTS FOR MEETING MEANINGFUL USE OF EHRs 1

UCSF. MyResearch 101. warren.steele@ucsf.edu Presented by. ITS Academic Research Systems. Powered by

Find the signal in the noise

Using Health Information Technology to Improve Quality of Care: Clinical Decision Support

Stage 1 measures. The EP/eligible hospital has enabled this functionality

Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)

Stage 1 vs. Stage 2 Comparison for Eligible Professionals

Meaningful Use Objectives

EMR Name/ Model. meridianemr 4.2 CCHIT 2011 certified

THE ROLE OF CLINICAL DECISION SUPPORT AND ANALYTICS IN IMPROVING LONG-TERM CARE OUTCOMES

Electronic Health Record (EHR) Data Analysis Capabilities

Stage 1 measures. The EP/eligible hospital has enabled this functionality

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

The EP/eligible hospital has enabled this functionality. At least 80% of all unique patients. seen by the EP or admitted to the

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Contents: Centers for Medicare/Medicaid (CMS) Clinical Trials Policy (CTP) Training. CMS CTP Background, Definitions and Requirements

Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015

Canada Health Infoway

Meaningful Use of Certified EHR Technology with My Vision Express*

AAP Meaningful Use: Certified EHR Technology Criteria

Using EHRs to extract information, query clinicians, and insert reports

Where to Begin? Auditing the Current EHR System

Qualifying for Medicare Incentive Payments with Crystal Practice Management. Version

Meaningful Use. Michael L. Brody, DPM FACFAOM CCHIT Ambulatory Workgroup HITSP Physician Perspective Technical Committee NYeHC

Clinical Data Services

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

Creating a national electronic health record: The Canada Health Infoway experience

MEANINGFUL USE STAGE 2 USERS GUIDE

Public Health and the Learning Health Care System Lessons from Two Distributed Networks for Public Health

Prevent what is preventable, cure what is curable, provide palliative care for patients in need, and monitor and manage for results.

Medicaid EHR Incentive Program. Focus on Stage 2. Kim Davis-Allen, Outreach Coordinator

HL7 & Meaningful Use. Charles Jaffe, MD, PhD CEO Health Level Seven International. HIMSS 11 Orlando February 23, 2011

Core Set of Objectives and Measures Must Meet All 15 Measures Stage 1 Objectives Stage 1 Measures Reporting Method

Appendix 6.2 Data Source Described in Detail Hospital Data Sets

How To Analyze Health Data

TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET

Healthy Living with Diabetes. Diabetes Disease Management Program

Contact Information: West Texas Health Information Technology Regional Extension Center th Street MS 6232 Lubbock, Texas

Health Information Technology and the National Quality Agenda. Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations

Session 1: Core Pharmaceutical Datasets Retail and Non Retail Laura Jenkins Jirele

2013 Meaningful Use Dashboard Calculation Guide

39. Supplemental Data

Big Data Integration and Governance Considerations for Healthcare

Practical Development and Implementation of EHR Phenotypes. NIH Collaboratory Grand Rounds Friday, November 15, 2013

STAGE 2 of the EHR Incentive Programs

Research Opportunities using the PaTH Network

Plan and manage clinical trials with clarity and confidence

A pharmacist s guide to Pharmacy Services compensation

Presented by. Terri Gonzalez Director of Practice Improvement North Carolina Medical Society

EMR Systems and the Conduct of Clinical Research. Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine

Treatment of Low Risk MDS. Overview. Myelodysplastic Syndromes (MDS)

MICROMD EMR VERSION OBJECTIVE MEASURE CALCULATIONS

EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.)

Using Large Datasets for Population-based Health Services Research

MEANINGFUL USE. Community Center Readiness Guide Additional Resource #13 Meaningful Use Implementation Tracking Tool (Template) CONTENTS:

How to extract transform and load observational data?

Research Data Extraction Service. Research and Woodruff Health Sciences IT

Meaningful Use Qualification Plan

Transcription:

Environmental Health Science Data Streams Health Data Brian S. Schwartz, MD, MS January 10, 2013

When is a data stream not a data stream? When it is health data. EHR data = PHI of health system Data stream IRB approval, data pull (by IT), data transfer (to researchers), data cleaning, variable creation ( phenotyping of patients), data merging, environmental metrics, data analysis (computationally intensive person, place, time)

Using EHR Data: An Example Using longitudinal EHR data, how do we know if a patient has diabetes? When does observation of the patient begin? With EHR data cannot determine enrollment (health plan data) When did the patient s diabetes begin? How do we distinguish type 1 from type 2? What does it mean if a HbA1c level exists, or diabetes treatment began, before any ICD-9 code for diabetes? How do we define diabetes severity? How do we avoid confounding by indication? In observational studies of drug effects, drugs are not assigned randomly; indication for treatment may be related to risk of future health outcomes

The Natural History of Diabetes Healthy Pre-diabetes Diabetes Complications 100 mg/dl FBS 125mg/dL HbA1c (screening) ICD-9 code HbA1c (monitoring) Rx mean duration = 159d mean duration = 117d mean duration = 1534d HbA1c (pre-therapeutic) 1 st ICD-9 diabetes code HbA1c (post-icd-9) HbA1c (last-ever) n = 7337 mean = 7.51% n = 17,959 mean = 7.64% mean duration = 1732 days

NIH Research Collaboratory Council of Councils Meeting, July 1, 2010 NIH-HMORN Collaboratory: Common Fund Proposal Purpose: The NIH-HMORNHMORN Collaboratory will enhance and strengthen a research platform to accelerate large epidemiology studies, pragmatic clinical trials, and EHR-enabled health care delivery research by leveraging g the HMORN's scientific, data and operational infrastructure. Limited competition U54 RFP released 2-17-2011, then changed. Duke Clinical Research Institute awarded $9M from NIH to serve as the Coordinating Center for NIH s Health Care Systems Research Collaboratory 9/25/12 press release The goal of the Collaboratory is to involve clinicians and patients in the design and interpretation of trials, provide the education needed to enhance the value of their participation, and use the data collected during healthcare delivery as the core data source for the full spectrum of clinical research, from registries to observational studies and pragmatic randomized controlled trials.

Virtual Data Warehouse NIH-HMORN Collaboratory included a goal to develop a VDW The objectives of this initiative are to improve data quality; enable cross-sitesite and cross project synergies; balance site-, project-, and network-level priorities; and reduce the preparatory work needed to assemble cohorts, count events, and capture exposure and co-morbidity data, all in support of an array of different types of studies. HMO-RN members have been working on a VDW An internal website provides metadata (years, variable descriptions, labels, formats, definitions, specification, coding) HMORN has developed guidelines and policies to facilitate research, but control resides at each member site Efforts to write programs to extract & convert variables stored in legacy information systems to common standards; test standardized data for consistency & accuracy; standardize di methods by providing macros & programs that are used across sites; provide instructions on how to use VDW to create analytic files for research

The VDW Not a centralized data warehouse; it consists of parallel, identical databases at each HMORN site, to facilitate merging across sites It is not an analytic dataset, but does facilitate creation of such As of March 2011, VDW data domains include: Demographics: date of birth, gender, race and ethnicity Enrollment: health plan membership enrollment, with insurance types, benefits, effective dates of coverage Encounters: OPT, IPT, with associated diagnosis and procedure codes, type of encounter, provider seen, facility and discharge disposition Procedures: performed procedures (e.g., surgery, lab, radiology, immunization); various coding systems (CPT, HCPCS, ICD 9, insurance claims Revenue Codes) Diagnoses: dates, diagnosis codes, provider Providers: specialty, age, gender, race and year graduated Cancer/Tumor Registry: Surveillance, Epidemiology and End Results (SEER) program standards most complex domain of VDW Pharmacy Dispensing: date, National Drug or GPI code, therapeutic class, days supply, and amount dispensed Vital Signs: height, weight, blood pressure, tobacco use and type Laboratory Values: originally HbA1c, S-Cr, INR, FBG, serum K; values are being added through a timed priority list of 57 types of lab tests

In multisite studies, sitelevel differences in disease incidence, predictive variables, and health outcomes can represent: True small area variation in practice patterns & outcomes Variability in data collection methods across sites Data quality assessments across sites are a critical first step in multisite studies Kahn, et al., Medical Care, 2012

1)Type of data HEALTH data from electronic health records At Geisinger, i 400K+ primary care patients, t hundreds d of millions of records; many kinds of health information 2) What is the current status of data collection/archiving? Most patient health information will be collected electronically in the coming years There is no single repository for US health data Health systems most often use programs such as Epic; they then export data from Epic to a data warehouse for more easy access; and export from the warehouse for analysis There is no centralized warehouse; there are mechanisms for gaining access; there is no centralized catalog 3) Non technical aspects of sharing These data are not public; they can be accessed after agreements are in place, most often in collaborative research relationships; there is no routine sharing Creating a single national repository of EHR data would be a daunting task

4) Standardization in description of the data Many types of data: dates, encounters, diagnoses, ICD-9 and CPT codes, laboratory test codes with results, procedure test codes sometimes with results, physician orders, medications, imaging Variation across providers, clinics, health systems I do not believe there are as yet many ontology or metadata standards; text searching is necessary and natural language processing in early development 5) Movement and ability to combine with other data The health data are for INDIVIDUAL patients; individual patients cannot be directly linked to family members Health data can be linked to other data by location (generally residential address) and date (space and time) In general, approaches to analysis of EHR data are on a study by study basis Data have to be accessed, exported, used to create analytic variables, merged with other data, analyzed Epic has some analysis tools; in general we export data and use biostatistical software programs 6) Specific example: scientific question limited by integration challenges As long as other data have meaning in space and time there should not be obstacles to integration Have to acknowledge we may not be able to get what we actually want we use surrogates for exposure

Thank you for listening Second Presentation ENDS HERE